Market revenue in 2023 | USD 91.5 million |
Market revenue in 2030 | USD 151.3 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-house, Outsourcing |
Key market players worldwide | Genpact Ltd, Criterium Inc., Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Labcorp Holdings Inc, FREYR Battery Inc, Pharmexon, Cambridge Design Partnership, Voisin Consulting Life Sciences, Accell, PAREXEL, Promedica International, PharmaLex, NDA Regulatory Service GmbH, QVigilance, BlueReg Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.14% in 2023. Horizon Databook has segmented the South Africa regulatory affairs market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa is the largest market for pharmaceuticals in Sub-Saharan Africa region and has one of the most developed infrastructure and manufacturing facilities in the world. In addition, local presence of significant number of life sciences companies such as Adcock Ingram, Aspen Holdings, and Genius Biotherapeutics is anticipated to propel growth.
The government is planning to initiate new industrialization programs and policies such as the Ketlaphela project, which are likely to attract biopharmaceutical companies to this region, thereby contributing to the increasing demand for regulatory services.
Currently, Medicines Control Council (MCC) is the primary regulatory agency and one of the major challenges faced is regulatory approval process, which takes very long time. The 2015 Amendment has made a provision for the replacement of MCC by South African Health Product Regulatory Agency (SAHPRA), which will handle the regulatory approval processes related to the life sciences sector.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into South Africa regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account